Probabilidades
|
AVC – grupo controle |
8% |
55. Jäämaa-Holmberg S, Salmela B, Suojaranta R, Jokinen JJ, Lemström KB, Lommi J. Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock: Patient Survival and Health-related Quality of Life. Eur J Cardiothorac Surg. 2019;55(4):780-7. doi: 10.1093/ejcts/ezy374. https://doi.org/10.1093/ejcts/ezy374...
, § |
4% - 16% |
2626. Marra MP, Gasparetto N, Salotti C, Prevedello F, Marzari A, Bianco R, et al. Clinical Impact of Mechanical Supports for Management of Post-infarction Cardiogenic Shock: A Balance Between Survival and Hemorrhagic Complications in a Single Tertiary Centre. Eur Heart J. 2013;34(Suppl 1):5461. doi: 10.1093/eurheartj/eht310.P5461. https://doi.org/10.1093/eurheartj/eht310...
, § |
AVC – VA-ECMO |
5,9% |
c |
3% - 12% |
66. Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, et al. Extracorporeal Life Support During Cardiac Arrest and Cardiogenic Shock: A Systematic Review and Meta-analysis. Intensive Care Med. 2016;42(12):1922-34. doi: 10.1007/s00134-016-4536-8. https://doi.org/10.1007/s00134-016-4536-...
, § |
TSR – grupo controle |
25% |
27
27. Sattler S, Khaladj N, Zaruba MM, Fischer M, Hausleiter J, Mehilli J, et al. Extracorporal Life Support (ECLS) in Acute Ischaemic Cardiogenic Shock. Int J Clin Pract. 2014;68(4):529-31. doi: 10.1111/ijcp.12380. https://doi.org/10.1111/ijcp.12380...
|
12,5% - 50% |
§ |
TSR – VA-ECMO |
22% |
c |
11% - 44% |
2727. Sattler S, Khaladj N, Zaruba MM, Fischer M, Hausleiter J, Mehilli J, et al. Extracorporal Life Support (ECLS) in Acute Ischaemic Cardiogenic Shock. Int J Clin Pract. 2014;68(4):529-31. doi: 10.1111/ijcp.12380. https://doi.org/10.1111/ijcp.12380...
,2828. Xie A, Phan K, Tsai YC, Yan TD, Forrest P. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest: A Meta-analysis. J Cardiothorac Vasc Anesth. 2015;29(3):637-45. doi: 10.1053/j.jvca.2014.09.005. https://doi.org/10.1053/j.jvca.2014.09.0...
, § |
Necessidade de TSR após a alta hospitalar |
5% |
29
29. Schiffl H, Lang SM, Fischer R. Long-term Outcomes of Survivors of ICU Acute Kidney Injury Requiring Renal Replacement Therapy: A 10-year Prospective Cohort Study. Clin Kidney J. 2012;5(4):297-302. doi: 10.1093/ckj/sfs070. https://doi.org/10.1093/ckj/sfs070...
|
3% - 10% |
2929. Schiffl H, Lang SM, Fischer R. Long-term Outcomes of Survivors of ICU Acute Kidney Injury Requiring Renal Replacement Therapy: A 10-year Prospective Cohort Study. Clin Kidney J. 2012;5(4):297-302. doi: 10.1093/ckj/sfs070. https://doi.org/10.1093/ckj/sfs070...
, § |
Isquemia de membros – grupo controle |
6% |
2727. Sattler S, Khaladj N, Zaruba MM, Fischer M, Hausleiter J, Mehilli J, et al. Extracorporal Life Support (ECLS) in Acute Ischaemic Cardiogenic Shock. Int J Clin Pract. 2014;68(4):529-31. doi: 10.1111/ijcp.12380. https://doi.org/10.1111/ijcp.12380...
, § |
3% - 12% |
§ |
Isquemia de membros – VA-ECMO |
15% |
c |
7,3% - 29,4% |
c, § |
Amputação para isquemia de membros |
20% |
c |
10% - 40% |
§ |
Sangramento – grupo controle |
12% |
26
26. Marra MP, Gasparetto N, Salotti C, Prevedello F, Marzari A, Bianco R, et al. Clinical Impact of Mechanical Supports for Management of Post-infarction Cardiogenic Shock: A Balance Between Survival and Hemorrhagic Complications in a Single Tertiary Centre. Eur Heart J. 2013;34(Suppl 1):5461. doi: 10.1093/eurheartj/eht310.P5461. https://doi.org/10.1093/eurheartj/eht310...
|
15% - 60% |
§ |
Sangramento – VA-ECMO |
41,2% |
c |
20,6% - 82,4% |
c, § |
Anemia após a alta em caso de sangramento |
53% |
30
30. Bateman AP, McArdle F, Walsh TS. Time Course of Anemia During Six Months Follow up Following Intensive Care Discharge and Factors Associated with Impaired Recovery of Erythropoiesis. Crit Care Med. 2009;37(6):1906-12. doi: 10.1097/CCM.0b013e3181a000cf. https://doi.org/10.1097/CCM.0b013e3181a0...
|
26,5% - 100% |
3030. Bateman AP, McArdle F, Walsh TS. Time Course of Anemia During Six Months Follow up Following Intensive Care Discharge and Factors Associated with Impaired Recovery of Erythropoiesis. Crit Care Med. 2009;37(6):1906-12. doi: 10.1097/CCM.0b013e3181a000cf. https://doi.org/10.1097/CCM.0b013e3181a0...
, § |
Embolia pulmonar – grupo controle |
9,1% |
31
31. Darze ES, Latado AL, Guimarães AG, Guedes RA, Santos AB, Moura SS, et al. Incidence and Clinical Predictors of Pulmonary Embolism in Severe Heart Failure Patients Admitted to a Coronary Care Unit. Chest. 2005;128(4):2576-80. doi: 10.1378/chest.128.4.2576. https://doi.org/10.1378/chest.128.4.2576...
|
4,5% - 18% |
3131. Darze ES, Latado AL, Guimarães AG, Guedes RA, Santos AB, Moura SS, et al. Incidence and Clinical Predictors of Pulmonary Embolism in Severe Heart Failure Patients Admitted to a Coronary Care Unit. Chest. 2005;128(4):2576-80. doi: 10.1378/chest.128.4.2576. https://doi.org/10.1378/chest.128.4.2576...
, § |
Embolia pulmonar – VA-ECMO |
14,7% |
c |
7,35% - 29,4% |
c, § |
HP após embolia pulmonar |
3,2% |
32
32. Ende-Verhaar YM, Cannegieter SC, Noordegraaf AV, Delcroix M, Pruszczyk P, Mairuhu AT, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism: A Contemporary View of the Published Literature. Eur Respir J. 2017;49(2):1601792. doi: 10.1183/13993003.01792-2016. https://doi.org/10.1183/13993003.01792-2...
,
33
33. National Guideline Centre. Venous Thromboembolism in Over 16s: Reducing the Risk of Hospital-acquired Deep Vein Thrombosis or Pulmonary Embolism. London: National Institute for Health and Care Excellence; 2018.
|
2% - 4,4% |
32
32. Ende-Verhaar YM, Cannegieter SC, Noordegraaf AV, Delcroix M, Pruszczyk P, Mairuhu AT, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism: A Contemporary View of the Published Literature. Eur Respir J. 2017;49(2):1601792. doi: 10.1183/13993003.01792-2016. https://doi.org/10.1183/13993003.01792-2...
,
33
33. National Guideline Centre. Venous Thromboembolism in Over 16s: Reducing the Risk of Hospital-acquired Deep Vein Thrombosis or Pulmonary Embolism. London: National Institute for Health and Care Excellence; 2018.
|
Sobrevida – VA-ECMO |
54,9% |
c, 66. Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, et al. Extracorporeal Life Support During Cardiac Arrest and Cardiogenic Shock: A Systematic Review and Meta-analysis. Intensive Care Med. 2016;42(12):1922-34. doi: 10.1007/s00134-016-4536-8. https://doi.org/10.1007/s00134-016-4536-...
|
41% - 75% |
c, 66. Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, et al. Extracorporeal Life Support During Cardiac Arrest and Cardiogenic Shock: A Systematic Review and Meta-analysis. Intensive Care Med. 2016;42(12):1922-34. doi: 10.1007/s00134-016-4536-8. https://doi.org/10.1007/s00134-016-4536-...
|
Sobrevida – grupo controle |
30,25% |
c, 66. Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, et al. Extracorporeal Life Support During Cardiac Arrest and Cardiogenic Shock: A Systematic Review and Meta-analysis. Intensive Care Med. 2016;42(12):1922-34. doi: 10.1007/s00134-016-4536-8. https://doi.org/10.1007/s00134-016-4536-...
|
23% - 41% |
c, 66. Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, et al. Extracorporeal Life Support During Cardiac Arrest and Cardiogenic Shock: A Systematic Review and Meta-analysis. Intensive Care Med. 2016;42(12):1922-34. doi: 10.1007/s00134-016-4536-8. https://doi.org/10.1007/s00134-016-4536-...
|
RR para morte hospitalar – VA-ECMO vs. controle |
0,551 |
c, 66. Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, et al. Extracorporeal Life Support During Cardiac Arrest and Cardiogenic Shock: A Systematic Review and Meta-analysis. Intensive Care Med. 2016;42(12):1922-34. doi: 10.1007/s00134-016-4536-8. https://doi.org/10.1007/s00134-016-4536-...
|
0,375 - 0,809 |
c, 66. Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, et al. Extracorporeal Life Support During Cardiac Arrest and Cardiogenic Shock: A Systematic Review and Meta-analysis. Intensive Care Med. 2016;42(12):1922-34. doi: 10.1007/s00134-016-4536-8. https://doi.org/10.1007/s00134-016-4536-...
|
IC após a alta |
45% |
11
11. Lauridsen MD, Rorth R, Butt JH, Kristensen SL, Schmidt M, Moller JE, et al. Five-year Risk of Heart Failure and Death Following Myocardial Infarction with Cardiogenic Shock: A Nationwide Cohort Study. Eur Heart J Acute Cardiovasc Care. 2021;10(1):40-9. doi: 10.1093/ehjacc/zuaa022. https://doi.org/10.1093/ehjacc/zuaa022...
,
12
12. Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, et al. Long-term Survival and Outcomes After Hospitalization for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Clin Cardiol. 2009;32(8):4-8. doi: 10.1002/clc.20488. https://doi.org/10.1002/clc.20488...
|
40% - 50% |
11
11. Lauridsen MD, Rorth R, Butt JH, Kristensen SL, Schmidt M, Moller JE, et al. Five-year Risk of Heart Failure and Death Following Myocardial Infarction with Cardiogenic Shock: A Nationwide Cohort Study. Eur Heart J Acute Cardiovasc Care. 2021;10(1):40-9. doi: 10.1093/ehjacc/zuaa022. https://doi.org/10.1093/ehjacc/zuaa022...
,
12
12. Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, et al. Long-term Survival and Outcomes After Hospitalization for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Clin Cardiol. 2009;32(8):4-8. doi: 10.1002/clc.20488. https://doi.org/10.1002/clc.20488...
|
DAC após a alta |
48% |
c |
30% - 60% |
c, § |
Outras variáveis
|
Sobrevida média – IC (anos) |
5,92 |
34
34. Bertoldi EG, Rohde LE, Zimerman LI, Pimentel M, Polanczyk CA. Cost-effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure: The Perspective of a Middle-income Country's Public Health System. Int J Cardiol. 2013;163(3):309-15. doi: 10.1016/j.ijcard.2011.06.046. https://doi.org/10.1016/j.ijcard.2011.06...
|
2,52 - 5,95 |
35
35. Bocchi EA, Cruz FDD, Brandão SM, Issa V, Ayub-Ferreira SM, la Rocca HPB, et al. Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial Results. J Card Fail. 2018;24(10):627-37. doi: 10.1016/j.cardfail.2018.04.008. https://doi.org/10.1016/j.cardfail.2018....
,
36
36. Ribeiro RA, Stella SF, Zimerman LI, Pimentel M, Rohde LE, Polanczyk CA. Cost-effectiveness of Implantable Cardioverter Defibrillators in Brazil in the Public and Private Sectors. Arq Bras Cardiol. 2010;95(5):577-86. doi: 10.1590/s0066-782x2010005000134. https://doi.org/10.1590/s0066-782x201000...
|
Sobrevida média – DAC (anos) |
11,4 |
1414. Ribeiro RA, Duncan BB, Ziegelmann PK, Stella SF, Vieira JL, Restelatto LM, et al. Cost-effectiveness of High, Moderate and Low-dose Statins in the Prevention of Vascular Events in the Brazilian Public Health System. Arq Bras Cardiol. 2015;104(1):32-44. doi: 10.5935/abc.20140173. https://doi.org/10.5935/abc.20140173...
, § |
8 - 16 |
1414. Ribeiro RA, Duncan BB, Ziegelmann PK, Stella SF, Vieira JL, Restelatto LM, et al. Cost-effectiveness of High, Moderate and Low-dose Statins in the Prevention of Vascular Events in the Brazilian Public Health System. Arq Bras Cardiol. 2015;104(1):32-44. doi: 10.5935/abc.20140173. https://doi.org/10.5935/abc.20140173...
, § |
Sobrevida ajustada – IC (QALY) |
4,4 |
34
34. Bertoldi EG, Rohde LE, Zimerman LI, Pimentel M, Polanczyk CA. Cost-effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure: The Perspective of a Middle-income Country's Public Health System. Int J Cardiol. 2013;163(3):309-15. doi: 10.1016/j.ijcard.2011.06.046. https://doi.org/10.1016/j.ijcard.2011.06...
|
3,99 - 5,23 |
35
35. Bocchi EA, Cruz FDD, Brandão SM, Issa V, Ayub-Ferreira SM, la Rocca HPB, et al. Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial Results. J Card Fail. 2018;24(10):627-37. doi: 10.1016/j.cardfail.2018.04.008. https://doi.org/10.1016/j.cardfail.2018....
,
36
36. Ribeiro RA, Stella SF, Zimerman LI, Pimentel M, Rohde LE, Polanczyk CA. Cost-effectiveness of Implantable Cardioverter Defibrillators in Brazil in the Public and Private Sectors. Arq Bras Cardiol. 2010;95(5):577-86. doi: 10.1590/s0066-782x2010005000134. https://doi.org/10.1590/s0066-782x201000...
|
Sobrevida ajustada – DAC (QALY) |
8,46 |
14
14. Ribeiro RA, Duncan BB, Ziegelmann PK, Stella SF, Vieira JL, Restelatto LM, et al. Cost-effectiveness of High, Moderate and Low-dose Statins in the Prevention of Vascular Events in the Brazilian Public Health System. Arq Bras Cardiol. 2015;104(1):32-44. doi: 10.5935/abc.20140173. https://doi.org/10.5935/abc.20140173...
|
6 - 11 |
14
14. Ribeiro RA, Duncan BB, Ziegelmann PK, Stella SF, Vieira JL, Restelatto LM, et al. Cost-effectiveness of High, Moderate and Low-dose Statins in the Prevention of Vascular Events in the Brazilian Public Health System. Arq Bras Cardiol. 2015;104(1):32-44. doi: 10.5935/abc.20140173. https://doi.org/10.5935/abc.20140173...
|
Sobrevida média saudável (anos) |
26,5 |
15
15. Instituto Brasileiro de Geografia e Estatística. Estatísticas de Mortalidade por Idade. [Internet]. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2023 [cited 2024 Mar 14]. Available from: www.ibge.gov.br. www.ibge.gov.br...
|
20 - 30 |
1515. Instituto Brasileiro de Geografia e Estatística. Estatísticas de Mortalidade por Idade. [Internet]. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2023 [cited 2024 Mar 14]. Available from: www.ibge.gov.br. www.ibge.gov.br...
, § |
Sobrevida ajustada saudável (QALY) |
20,14 |
37
37. Stevens B, Pezzullo L, Verdian L, Tomlinson J, George A, Bacal F. The Economic Burden of Heart Conditions in Brazil. Arq Bras Cardiol. 2018;111(1):29-36. doi: 10.5935/abc.20180104. https://doi.org/10.5935/abc.20180104...
,
38
38. Ciconelli RM, Ferraz MB, Kowalski S, Pinheiro GR, Sato EI. Brazilian Urban Population Norms Derived from the Health-related Quality of Life SF-6D. Qual Life Res. 2015;24(10):2559-64. doi: 10.1007/s11136-015-0991-x. https://doi.org/10.1007/s11136-015-0991-...
|
8,4 - 30 |
37
37. Stevens B, Pezzullo L, Verdian L, Tomlinson J, George A, Bacal F. The Economic Burden of Heart Conditions in Brazil. Arq Bras Cardiol. 2018;111(1):29-36. doi: 10.5935/abc.20180104. https://doi.org/10.5935/abc.20180104...
,
38
38. Ciconelli RM, Ferraz MB, Kowalski S, Pinheiro GR, Sato EI. Brazilian Urban Population Norms Derived from the Health-related Quality of Life SF-6D. Qual Life Res. 2015;24(10):2559-64. doi: 10.1007/s11136-015-0991-x. https://doi.org/10.1007/s11136-015-0991-...
|